In this context, interferon (IFN)-α-2 (2a and 2b), has been shown to induce major - and in a subset of patients also - complete molecular remissions in JAK2V617F-positive patients with essential thrombocytosis (ET) and PV [21]. This evidence concerns the gene IFNA2 and essential thrombocythemia.